Naomi Feingold, | |
291 Independence Dr, Chestnut Hill, MA 02467-3628 | |
(617) 325-2800 | |
Not Available |
Full Name | Naomi Feingold |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 291 Independence Dr, Chestnut Hill, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467503060 | NPI | - | NPPES |
39178 | Other | MA | HPHC |
CN0174 | Other | MA | BCBS |
0369420 | Medicaid | MA | |
4104066-001 | Other | MA | CIGNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
Entity Name | Atrius Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
The surgical future for heart patients in Canada's northlands or in isolated towns and villages, will lie increasingly in the hands of robots, says Dr. Alan Menkis.
A Leicester cancer research project, which receives funding from Hope Against Cancer (formerly The Hope Foundation,) is investigating whether an extract from bilberries can prevent or delay the onset of certain cancers.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Naomi Feingold, 291 Independence Dr, Chestnut Hill, MA 02467-3628 Ph: (617) 541-6450 | Naomi Feingold, 291 Independence Dr, Chestnut Hill, MA 02467-3628 Ph: (617) 325-2800 |
News Archive
The surgical future for heart patients in Canada's northlands or in isolated towns and villages, will lie increasingly in the hands of robots, says Dr. Alan Menkis.
A Leicester cancer research project, which receives funding from Hope Against Cancer (formerly The Hope Foundation,) is investigating whether an extract from bilberries can prevent or delay the onset of certain cancers.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.
› Verified 4 days ago
Mrs. Molly Hart Doyle, APRN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 291 Independence Dr, Chestnut Hill, MA 02467 Phone: 617-541-6450 | |
Caitlin Elizabeth Mayhew, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 291 Independence Dr, Chestnut Hill, MA 02467 Phone: 617-541-6600 |